AK
Anil Kumar Saini
About Anil Kumar Saini
Data last updated:
Anil Kumar Saini is a Director at Midway Pharmaceuticals Private Limited (since 2024) and Director at Nmr Industries Limited (since 2024). The companies operate in Pharma and Fashion and Textile. The 2 current companies with reported revenue have a combined latest revenue of ₹6.98 Cr; the largest is Midway Pharmaceuticals Private Limited at ₹4.28 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Midway Pharmaceuticals Private Limited U24239DL2004PTC124433 | Director | 02 Feb 2024 | 2004 | ₹4.28 Cr (FY 2023) | Active |
 Nmr Industries Limited U51909DL2009PLC192865 | Director | 17 Mar 2024 | 2009 | ₹2.70 Cr (FY 2022) | Active |
Board colleagues of Anil Kumar Saini
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mukesh Kumar Saini | 01046102 | Midway Pharmaceuticals Private Limited , Nmr Industries Limited | Director |
| Rishi Saini | 08286613 | Nmr Industries Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anil Kumar Saini
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anil Kumar Saini
Anil Kumar Saini currently holds 2 directorships: Midway Pharmaceuticals Private Limited (Director, since 02 Feb 2024, revenue ₹4.28 Cr (FY 2023)); Nmr Industries Limited (Director, since 17 Mar 2024, revenue ₹2.70 Cr (FY 2022)).
Anil Kumar Saini was first appointed on 02 Feb 2024 as Director at Midway Pharmaceuticals Private Limited.
The 2 current companies of Anil Kumar Saini that report revenue have a combined latest revenue of ₹6.98 Cr: Midway Pharmaceuticals Private Limited ₹4.28 Cr (FY 2023); Nmr Industries Limited ₹2.70 Cr (FY 2022).
The current boards of Anil Kumar Saini's companies include Mukesh Kumar Saini (Midway Pharmaceuticals Private Limited), Rishi Saini (Nmr Industries Limited).